Boxer Capital’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-2,946,915
| Closed | -$30.1M | – | 23 |
|
2024
Q3 | $30.1M | Hold |
2,946,915
| – | – | 1.48% | 17 |
|
2024
Q2 | $43.7M | Buy |
2,946,915
+1,142,857
| +63% | +$17M | 2.3% | 13 |
|
2024
Q1 | $24.6M | Hold |
1,804,058
| – | – | 1.22% | 25 |
|
2023
Q4 | $19.8M | Hold |
1,804,058
| – | – | 0.98% | 28 |
|
2023
Q3 | $19.8M | Sell |
1,804,058
-350,000
| -16% | -$3.83M | 1.05% | 32 |
|
2023
Q2 | $28.5M | Hold |
2,154,058
| – | – | 1.32% | 27 |
|
2023
Q1 | $29.3M | Hold |
2,154,058
| – | – | 1.44% | 21 |
|
2022
Q4 | $42.1M | Hold |
2,154,058
| – | – | 2.22% | 13 |
|
2022
Q3 | $41M | Hold |
2,154,058
| – | – | 2.31% | 13 |
|
2022
Q2 | $44.4M | Sell |
2,154,058
-1,038,000
| -33% | -$21.4M | 2.81% | 11 |
|
2022
Q1 | $103M | Sell |
3,192,058
-1,152,958
| -27% | -$37.1M | 5.28% | 3 |
|
2021
Q4 | $202M | Hold |
4,345,016
| – | – | 7.86% | 3 |
|
2021
Q3 | $117M | Hold |
4,345,016
| – | – | 4.1% | 4 |
|
2021
Q2 | $111M | Hold |
4,345,016
| – | – | 3.93% | 4 |
|
2021
Q1 | $149M | Hold |
4,345,016
| – | – | 5.04% | 5 |
|
2020
Q4 | $147M | Hold |
4,345,016
| – | – | 4.72% | 4 |
|
2020
Q3 | $107M | Buy |
+4,345,016
| New | +$107M | 3.7% | 5 |
|